Provided by Tiger Fintech (Singapore) Pte. Ltd.

Penumbra

272.73
-4.6250-1.67%
Volume:44.39K
Turnover:12.19M
Market Cap:10.55B
PE:757.57
High:278.59
Open:278.06
Low:272.72
Close:277.35
Loading ...

Penumbra upgraded to Overweight from Equal Weight at Wells Fargo

TIPRANKS
·
11 Dec 2024

New NCCN Guidelines Boost Myriad Genetics' Prolaris: Stock to Gain?

Zacks
·
10 Dec 2024

Penumbra (PEN) is an Incredible Growth Stock: 3 Reasons Why

Zacks
·
10 Dec 2024

Penumbra Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
10 Dec 2024

Penumbra price target raised to $323 from $260 at Canaccord

TIPRANKS
·
09 Dec 2024

QIAGEN Stock Might Rise Following 1000 EZ2 Connect Placements

Zacks
·
09 Dec 2024

Why Penumbra (PEN) is a Top Growth Stock for the Long-Term

Zacks
·
06 Dec 2024

CRL Stock to Gain From the Global Biotech Incubator Program Launch

Zacks
·
06 Dec 2024

ZBH Stock Might Rise Following FDA Nod for Knee Implant Component

Zacks
·
05 Dec 2024

TMO Stock to Gain From the New Additions to CTS Portfolio of Products

Zacks
·
05 Dec 2024

Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS?

Zacks
·
04 Dec 2024

New Health Coaching Service on questhealth.com Set to Boost DGX Stock

Zacks
·
04 Dec 2024

Reasons to Retain EYE Stock in Your Portfolio for Now

Zacks
·
04 Dec 2024

Bruker Stock Might Rise From the Launch of Dimension Nexus AFM

Zacks
·
03 Dec 2024

HOLX Stock Set to Gain From New Study Data on Genius AI Detection 2.0

Zacks
·
03 Dec 2024

Is Penumbra Stock a Smart Buy for Your Portfolio Right Now?

Zacks
·
03 Dec 2024

Reasons to Add Phibro Stock to Your Portfolio Right Now

Zacks
·
02 Dec 2024

Should You Continue to Retain Bio-Techne Stock in Your Portfolio?

Zacks
·
02 Dec 2024

GMED vs. PEN: Which Stock Should Value Investors Buy Now?

Zacks
·
30 Nov 2024

Why Is Penumbra (PEN) Up 6.7% Since Last Earnings Report?

Zacks
·
30 Nov 2024